Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Moodys
Accenture
Fuji
Merck
McKesson
Healthtrust
Mallinckrodt

Generated: July 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,778,999

« Back to Dashboard

Which drugs does patent 8,778,999 protect, and when does it expire?

Patent 8,778,999 protects BROMSITE and is included in one NDA.

This patent has four patent family members in six countries.
Summary for Patent: 8,778,999
Title:Non-steroidal anti-inflammatory ophthalmic compositions
Abstract: The disclosure provides compositions and systems for topical ophthalmic application, which include an aqueous mixture of bromfenac and flowable mucoadhesive polymer, for treating inflammation and inflammatory conditions of the eye.
Inventor(s): Hosseini; Kamran (Los Altos, CA), Bowman; Lyle (Pleasanton, CA), Si; Erwin C. (Alameda, CA), Pham; Stephen (Sacramento, CA)
Assignee: Insite Vision Incorporated (Alameda, CA)
Application Number:12/398,657
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 8,778,999

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sun Pharma Global BROMSITE bromfenac sodium SOLUTION/DROPS;OPHTHALMIC 206911-001 Apr 8, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y TREATMENT OF POSTOPERATIVE INFLAMMATION AND PREVENTION OF OCULAR PAIN IN PATIENTS UNDERGOING CATARACT SURGERY ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 8,778,999

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2753947 ➤ Try a Free Trial
Denmark 2403493 ➤ Try a Free Trial
European Patent Office 2403493 ➤ Try a Free Trial
Spain 2586064 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Healthtrust
Cipla
Covington
Chubb
Cantor Fitzgerald
Baxter
Federal Trade Commission
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.